WallStreetZenWallStreetZen

NASDAQ: LGND
Ligand Pharmaceuticals Inc Stock Ownership - Who owns Ligand Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Ligand Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
John W. KozarichDirector2024-04-242,893$39.35
$113.84kBuy
Todd C. DavisChief Executive Officer2024-03-252,156$68.51
$147.71kBuy
Todd C. DavisChief Executive Officer2024-03-257,448$46.20
$344.10kBuy
Todd C. DavisChief Executive Officer2024-03-252,855$67.24
$191.97kBuy
Todd C. DavisChief Executive Officer2024-03-253,556$66.19
$235.37kBuy
Jason AryehDirector2024-03-052,893$39.35
$113.84kBuy
Stephen L. SabbaDirector2024-03-051,893$74.30
$140.65kSell
Octavio EspinozaChief Financial Officer2024-02-28799$55.75
$44.54kBuy
Octavio EspinozaChief Financial Officer2024-02-28140$88.46
$12.38kSell
Octavio EspinozaChief Financial Officer2024-02-28325$58.49
$19.01kBuy

1 of 3

LGND insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LGND insiders and whales buy or sell their stock.

LGND Shareholders

What type of owners hold Ligand Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Partners L P357.72%63,334,719$4.47BInsider
David M. Knott71.23%12,611,277$889.98MInsider
Daniel S. Loeb55.10%9,754,756$688.39MInsider
Investment 10 LLC20.23%3,582,065$252.79MInsider
Blackrock Inc16.73%2,962,314$209.05MInstitution
Vanguard Group Inc10.60%1,876,514$132.43MInstitution
Janus Henderson Group PLC7.59%1,343,154$94.79MInstitution
Macquarie Group Ltd5.58%987,354$69.68MInstitution
Goldman Sachs Group Inc3.88%686,330$48.43MInsider
State Street Corp3.77%668,284$47.16MInstitution

1 of 3

LGND vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LGND14.99%85.01%Net SellingNet Buying
VRNA10.44%55.94%Net SellingNet Selling
KNSA48.25%9.83%Net SellingNet Selling
SLNO20.62%79.38%Net BuyingNet Selling
XNCR66.74%33.26%Net BuyingNet Selling
View Top Biotech Stocks

Ligand Pharmaceuticals Stock Ownership FAQ

Who owns Ligand Pharmaceuticals?

Ligand Pharmaceuticals (NASDAQ: LGND) is owned by 91.22% institutional shareholders, 517.46% Ligand Pharmaceuticals insiders, and 0.00% retail investors. Bvf Partners L P is the largest individual Ligand Pharmaceuticals shareholder, owning 63.33M shares representing 357.72% of the company. Bvf Partners L P's Ligand Pharmaceuticals shares are currently valued at $4.47B.

If you're new to stock investing, here's how to buy Ligand Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.